|
|
|
Stem Cell Related Patent Number US6383481
| Title: | Method for transplantation of hemopoietic stem cells | | Inventors: | Ikehara, Susumu; Osaka, Japan
Inaba, Muneo; Kyoto, Japan
Takeuchi, Kenji; Osaka, Japan
Kushida, Taketoshi; Amagasaki, Japan | | Summary: | Described herein is a novel pharmaceutical composition for hematopoietic stem cell transplantation, composed of hematopoietic stem cells that are irradiated with an effective dose of radiation as an active ingredient. The invention relates to a method of transplanting hemopoietic stem cells via subjecting a recipient to a radiation treatment using an effective exposure dose for hemopoietic stem cell transplantation in advance of administering hemopoietic stem cells from a donor via the portal vein, thereby avoiding the graft failure and rejection rate of donor cells. Specific therapeutic applications in the treatment of autoimmune diseases are included. | | Abstract: | This invention relates to a method of transplanting hemopoietic stem cells which Comprises subjecting a recipient to a radiation treatment using an effective exposure dose for hemopoietic stem cell transplantation in advance and administering hemopoietic stem cells from a donor from the portal vein. By this method the graft failure/rejection of donor cells can be avoided to thereby maintain the transplant in satisfactory condition. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6383481 | | Application Number: | US1999000265418 | | Date Filed: | 10/03/1999 | | Date Published: | 07/05/2002 | | Assignee: | Japan Immunoresearch Laboratories Co., Ltd., Gunma-Ken, Japan |
|
|
